home / stock / azta / azta news


AZTA News and Press, Azenta Inc. From 08/30/22

Stock Information

Company Name: Azenta Inc.
Stock Symbol: AZTA
Market: NASDAQ
Website: brooks.com

Menu

AZTA AZTA Quote AZTA Short AZTA News AZTA Articles AZTA Message Board
Get AZTA Alerts

News, Short Squeeze, Breakout and More Instantly...

AZTA - Azenta to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Azenta to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference PR Newswire CHELMSFORD, Mass. , Aug. 30, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 2...

AZTA - Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference PR Newswire CHELMSFORD, Mass. , Aug. 11, 2022 /PRNewswi...

AZTA - Azenta, Inc. (AZTA) CEO Steve Schwartz on Q3 2022 Results - Earnings Call Transcript

Azenta, Inc. (AZTA) Q3 2022 Earnings Conference Call August 09, 2022, 04:30 PM ET Company Participants Sara Silverman - Director, IR Steve Schwartz - President & CEO Lindon Robertson - EVP & CFO Matt McManus - COO Conference Call Participants ...

AZTA - Azenta, Inc. 2022 Q3 - Results - Earnings Call Presentation

The following slide deck was published by Azenta, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Azenta, Inc. 2022 Q3 - Results - Earnings Call Presentation

AZTA - Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022

Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022 PR Newswire CHELMSFORD, Mass. , Aug. 9, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 20...

AZTA - Azenta to acquire vaccine cold chain firm B Medical Systems for Euro410M

Azenta ( NASDAQ: AZTA ) said Monday it will acquire B Medical Systems , a Luxembourg-based vaccine cold chain provider, for ~€410M in cash. Up to €50M may be paid on achieving certain performance targets. The deal is expected to be accretive to ...

AZTA - Azenta Announces Agreement to Acquire B Medical Systems

Azenta Announces Agreement to Acquire B Medical Systems PR Newswire Enhances Azenta's Leadership Position in Cold Chain Solutions and End-to-End Sample Management CHELMSFORD, Mass. , Aug. 8, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today a...

AZTA - Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit PR Newswire CHELMSFORD, Mass. , Aug. 5, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Genomics 2.0 and MedT...

AZTA - Azenta Celebrates Opening of New China Headquarters

Azenta Celebrates Opening of New China Headquarters PR Newswire CHELMSFORD, Mass. , July 27, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the opening of its new China headquarters in Suzhou, which serves as the hub for Azenta opera...

AZTA - Brasada Capital - Azenta Life Sciences: No Ordinary Company

Azenta's core markets are expected to grow 15%-20% per annum for the next five years. When looking at visibility of earnings approximately 75% of AZTA’s revenue is recurring with a customer base intent on storing for up to 25 years. This should lead to the conclusion this i...

Previous 10 Next 10